← All Clover Health Investments, CORP /DE filings

Clover Health Investments, CORP /DE DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
CLOV
Clover Health Investments, CORP /DE
DEF: Clover Health Annual Meeting Proxy Statement Released
Clover Health Investments, Corp. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
DEFA14A: Clover Health Investments Corp. Announces 2025 Annual Meeting and Proxy Voting Details
Clover Health Investments Corp. is holding its annual stockholder meeting on June 10, 2025, and has provided details on how stockholders can vote on key proposals.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
DEF: Clover Health Investments Sets Date for 2025 Annual Stockholder Meeting, Outlines Key Proposals
Clover Health Investments will hold its annual stockholder meeting virtually on June 10, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
DEFA14A: Clover Health Investments Corp. Sets Date for 2024 Annual Meeting, Outlines Voting Matters
Clover Health Investments Corp. announces its 2024 Annual Meeting to be held virtually on June 10, 2024, outlining key proposals for stockholder voting including the election of directors, executive compensation, and auditor ratification.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
DEF 14A: Clover Health Investments Sets Date for 2024 Annual Stockholders Meeting
Clover Health Investments will hold its 2024 annual meeting of stockholders virtually on June 10, 2024, to vote on director elections, executive compensation, and the ratification of its accounting firm.